Konstantin A. Kaperiz
Konstantin A. Kaperiz has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Igor S. Yavelov
National Medical Research Center for Therapy and Preventive Medicine
6 shared publications - A. O. Rastatueva
National Medical Research Center for Therapy and Preventive Medicine
5 shared publications - Oksana Mikhailovna Drapkina
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
5 shared publications - Vadim Yu. Bogachev
Moscow Regional Research Clinical Institute named after M.F. Vladimirsky; First Phlebological Center
5 shared publications - Sergey V. Sapelkin
Vishnevsky National Medical Research Center of Surgery
4 shared publications - D. A. Feshchenko
National Medical Research Center for Therapy and Preventive Medicine
3 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by National Medical Research Center For Rehabilitation And Balneology in Bulletin of Rehabilitation Medicine
- Vol. 25 (4) , 83-95
Effectiveness of isokinetic training with biofeedback in comprehensive rehabilitation of patients with post-thrombotic syndrome: a quasi-experimental study
INTRODUCTION. Dysfunction of the lower leg muscle-venous pump (MVP) in post-thrombotic syndrome (PTS) can be considered a therapeutic target in the treatment of chronic venous insufficiency. Correction of muscle dysfunction and reduction of functional deficit (arthritic muscle inhibition / AMI) can be achieved by improving neuromuscular control and proprioception during robotic isokinetic MVP training, which will improve the effectiveness of comprehensive rehabilitation for PTS. AIM. To study the effectiveness of a comprehensive rehabilitation program using robotic isokinetic lower limb muscle training with biofeedback (BFB) on lower leg MVP performance and ankle range of motion in patients with PTS. MATERIALS AND METHODS. The study included 30 patients with lower extremity PTS (C3–C5 according to the CEAP classification), with an average age of 57.24 ± 10.17 years, a disease duration of 8.67 ± 1.14 years, and a BMI of 32.61 ± 5.81 kg/m2. All patients had a documented history of DVT of varying duration. The dynamics of the ankle joint range of motion (AROM) (dorsiflexion, plantar flexion) indicators were studied in degrees according to goniometry data. The performance indicators of the lower leg MVP were investigated according to isokinetic dynamometry of the lower limb muscles, including peak torque, work of the extensor and flexor muscles of the foot and the fatigue coefficient characterizing proprioception. Each patient underwent measurements before and after a rehabilitation course, including intermittent pneumatic compression of the legs No. 12, intravenous laser irradiation of blood using Low-level laser radiation in the infrared range (wavelength 890 nm) No. 12, as well as 12 isokinetic training sessions on a robotic Isokinetic Extremity System "Leg press" with biofeedback. The study was conducted at the National Medical Research Center for Rehabilitation and Balneology from February 2024 to August 2025. RESULTS. At baseline, patients with PTS showed a significant decrease in muscle strength in both limbs (affected and intact). In the affected limb with edema, the extensor strength deficit reached 55–64% of the lower limit of normal, and an even more pronounced deficit of 75–83 % was recorded for the flexors. Moreover, the muscles of the back of the leg (m. gastrocnemius, m. soleus) were weakened to a greater extent than the anterior tibialis and other dorsiflexors. After the rehabilitation course, an increase in AROM (dorsiflexion) goniometry values was noted from 9.88 ± 2.92° to 12.44 ± 4.35° (p 0.001); AROM (plantar flexion) from 26.90 ± 10.06° to 31.27 ± 9.08° (p 0.001). After the rehabilitation course, a significantly more pronounced improvement in the maximum extension torque on the affected limb was noted by 36 % (p = 0.019), compared with an increase of 16.1 % (p = 0.04) in the intact limb; an improvement in the relative extension torque on the intact limb was 45.5% (p = 0.006), compared with the affected limb, where the increase was 16.7 % (p = 0.028), indicating the effectiveness of MVP training in an isokinetic mode and with biofeedback, due to the correction of proprioceptive sensitivity, muscle strength, and, possibly, due to improved coordination abilities. A decrease in the malleolar circumference by 10.4 % (p 0.05) was also noted after treatment. DISCUSSION. In previous studies it has been proven that supravenous Low-level laser therapy provides an anti-inflammatory effect, reducing the severity of perivascular venous inflammation, while pressotherapy promotes lymphatic drainage in PTS. Isokinetic training is an effective method for increasing the hemodynamic efficiency of the muscle pump, overcoming the mechanisms of AMI by activating proprioceptors, as well as muscle strength, as evidenced by an increase in AROM, peak torque, overall work of the extensor and flexor muscles of the foot, and the fatigue coefficient. CONCLUSION. Incorporating isokinetic training of the lower extremity muscles into a rehabilitation program (with intermittent pneumatic compression and Low-level laser therapy) improves the function of the muscles involved in the MVP by reducing the identified functional deficit (AMI).
- 25 August 2026
- Published by National Medical Research Center For Rehabilitation And Balneology in Bulletin of Rehabilitation Medicine
- Vol. 25 (4) , 83-95
Open AccessEffectiveness of isokinetic training with biofeedback in comprehensive rehabilitation of patients with post-thrombotic syndrome: a quasi-experimental study
INTRODUCTION. Dysfunction of the lower leg muscle-venous pump (MVP) in post-thrombotic syndrome (PTS) can be considered a therapeutic target in the treatment of chronic venous insufficiency. Correction of muscle dysfunction and reduction of functional deficit (arthritic muscle inhibition / AMI) can be achieved by improving neuromuscular control and proprioception during robotic isokinetic MVP training, which will improve the effectiveness of comprehensive rehabilitation for PTS. AIM. To study the effectiveness of a comprehensive rehabilitation program using robotic isokinetic lower limb muscle training with biofeedback (BFB) on lower leg MVP performance and ankle range of motion in patients with PTS. MATERIALS AND METHODS. The study included 30 patients with lower extremity PTS (C3–C5 according to the CEAP classification), with an average age of 57.24 ± 10.17 years, a disease duration of 8.67 ± 1.14 years, and a BMI of 32.61 ± 5.81 kg/m2. All patients had a documented history of DVT of varying duration. The dynamics of the ankle joint range of motion (AROM) (dorsiflexion, plantar flexion) indicators were studied in degrees according to goniometry data. The performance indicators of the lower leg MVP were investigated according to isokinetic dynamometry of the lower limb muscles, including peak torque, work of the extensor and flexor muscles of the foot and the fatigue coefficient characterizing proprioception. Each patient underwent measurements before and after a rehabilitation course, including intermittent pneumatic compression of the legs No. 12, intravenous laser irradiation of blood using Low-level laser radiation in the infrared range (wavelength 890 nm) No. 12, as well as 12 isokinetic training sessions on a robotic Isokinetic Extremity System "Leg press" with biofeedback. The study was conducted at the National Medical Research Center for Rehabilitation and Balneology from February 2024 to August 2025. RESULTS. At baseline, patients with PTS showed a significant decrease in muscle strength in both limbs (affected and intact). In the affected limb with edema, the extensor strength deficit reached 55–64% of the lower limit of normal, and an even more pronounced deficit of 75–83 % was recorded for the flexors. Moreover, the muscles of the back of the leg (m. gastrocnemius, m. soleus) were weakened to a greater extent than the anterior tibialis and other dorsiflexors. After the rehabilitation course, an increase in AROM (dorsiflexion) goniometry values was noted from 9.88 ± 2.92° to 12.44 ± 4.35° (p 0.001); AROM (plantar flexion) from 26.90 ± 10.06° to 31.27 ± 9.08° (p 0.001). After the rehabilitation course, a significantly more pronounced improvement in the maximum extension torque on the affected limb was noted by 36 % (p = 0.019), compared with an increase of 16.1 % (p = 0.04) in the intact limb; an improvement in the relative extension torque on the intact limb was 45.5% (p = 0.006), compared with the affected limb, where the increase was 16.7 % (p = 0.028), indicating the effectiveness of MVP training in an isokinetic mode and with biofeedback, due to the correction of proprioceptive sensitivity, muscle strength, and, possibly, due to improved coordination abilities. A decrease in the malleolar circumference by 10.4 % (p 0.05) was also noted after treatment. DISCUSSION. In previous studies it has been proven that supravenous Low-level laser therapy provides an anti-inflammatory effect, reducing the severity of perivascular venous inflammation, while pressotherapy promotes lymphatic drainage in PTS. Isokinetic training is an effective method for increasing the hemodynamic efficiency of the muscle pump, overcoming the mechanisms of AMI by activating proprioceptors, as well as muscle strength, as evidenced by an increase in AROM, peak torque, overall work of the extensor and flexor muscles of the foot, and the fatigue coefficient. CONCLUSION. Incorporating isokinetic training of the lower extremity muscles into a rehabilitation program (with intermittent pneumatic compression and Low-level laser therapy) improves the function of the muscles involved in the MVP by reducing the identified functional deficit (AMI).
- Open Access
- 23 June 2026
- Published by National Medical Research Center For Rehabilitation And Balneology in Bulletin of Rehabilitation Medicine
- Vol. 25 (3)
Physical exercises as a method for correcting dysfunction of the calf muscle-venous pump in patients with post-thrombotic disease: a review
INTRODUCTION. Dysfunction of the calf muscle-venous pump (MVP) associated with venous obstruction contributes to ineffective venous blood emptying from the distal lower extremities and can be considered a therapeutic target in the treatment of chronic venous diseases. Physical exercise (PE) can be an effective method for increasing the hemodynamic efficiency of the MVP. AIM. A search and analytical review of research findings published in international databases, focusing on the role of MVP dysfunction in the pathogenesis of chronic venous insufficiency (CVI), as well as the effectiveness of various types of physical exercise. MATERIAL AND METHODS. Fifty-one sources were identified from databases eLibrary.RU, Scopus, PubMed, Web of Science from 1998 to 2025, of which 19 were systematic reviews, including two Cochrane reviews, five practice guidelines, and 27 randomized controlled trials. RESULTS. In patients with mild CVI, PE was found to improve venous reflux, muscle strength, ankle range of motion (AROM), and quality of life. In patients with severe CVI, PE increased ejection fraction, decreased residual volume, and improved muscle strength and AROM. Isotonic exercise was shown to improve muscle endurance, efficiency, and strength of the calf muscles, improving their contractility and overall hemodynamics in limbs with venous trophic ulcers (VTU). It was established that the effectiveness of MVP also depends on the mobility of the ankle joint and the calf muscles contractile strength. DISCUSSION. Despite the compelling evidence base for prescribing progressive strength training and aerobic activity to patients with VTU, there are no studies examining the effectiveness of isokinetic training in the comprehensive rehabilitation of patients with post-thrombotic syndrome (PTS). This underscores the need to develop modern isokinetic training protocols for patients with PTS, as they achieve improved performance through maximal muscle loading, which enhances motor learning through real-time feedback. CONCLUSION. Studying the effects of isokinetic exercise training on calf pump function, muscle strength, AROM, and quality of life in patients with PTS is a promising area of medical rehabilitation.
- 23 June 2026
- Published by National Medical Research Center For Rehabilitation And Balneology in Bulletin of Rehabilitation Medicine
- Vol. 25 (3)
Open AccessPhysical exercises as a method for correcting dysfunction of the calf muscle-venous pump in patients with post-thrombotic disease: a review
INTRODUCTION. Dysfunction of the calf muscle-venous pump (MVP) associated with venous obstruction contributes to ineffective venous blood emptying from the distal lower extremities and can be considered a therapeutic target in the treatment of chronic venous diseases. Physical exercise (PE) can be an effective method for increasing the hemodynamic efficiency of the MVP. AIM. A search and analytical review of research findings published in international databases, focusing on the role of MVP dysfunction in the pathogenesis of chronic venous insufficiency (CVI), as well as the effectiveness of various types of physical exercise. MATERIAL AND METHODS. Fifty-one sources were identified from databases eLibrary.RU, Scopus, PubMed, Web of Science from 1998 to 2025, of which 19 were systematic reviews, including two Cochrane reviews, five practice guidelines, and 27 randomized controlled trials. RESULTS. In patients with mild CVI, PE was found to improve venous reflux, muscle strength, ankle range of motion (AROM), and quality of life. In patients with severe CVI, PE increased ejection fraction, decreased residual volume, and improved muscle strength and AROM. Isotonic exercise was shown to improve muscle endurance, efficiency, and strength of the calf muscles, improving their contractility and overall hemodynamics in limbs with venous trophic ulcers (VTU). It was established that the effectiveness of MVP also depends on the mobility of the ankle joint and the calf muscles contractile strength. DISCUSSION. Despite the compelling evidence base for prescribing progressive strength training and aerobic activity to patients with VTU, there are no studies examining the effectiveness of isokinetic training in the comprehensive rehabilitation of patients with post-thrombotic syndrome (PTS). This underscores the need to develop modern isokinetic training protocols for patients with PTS, as they achieve improved performance through maximal muscle loading, which enhances motor learning through real-time feedback. CONCLUSION. Studying the effects of isokinetic exercise training on calf pump function, muscle strength, AROM, and quality of life in patients with PTS is a promising area of medical rehabilitation.
- 5 March 2026
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 29 (2) , 103-108
Relationship between chronic heart and venous insufficiency: possible mechanisms and clinical research findings
Chronic venous insufficiency (CVI) of the lower extremities is common and was once considered a localized disease. Recent evidence shows systemic effects of CVI, especially its link to the onset and progression of chronic heart failure (CHF). Objective. To characterize the possible relationships between chronic venous insufficiency of the lower extremities and chronic heart failure, to analyze the pathophysiological mechanisms of their interaction, as well as the role of chronic venous insufficiency of the lower extremities as a predictor of the development and progression of chronic heart failure. Materials and methods. The article reviews publications indicating a possible relationship between CVI and CHF. Sources were identified by searching the PubMed, eLibrary, and Google Scholar databases. Articles available in full-text, published from 2006 to 2025, were selected. Results. CVI has been shown to be associated with an increased risk of CHF, mortality, and adverse cardiovascular outcomes. Venous congestion and right heart dysfunction induce endothelial dysfunction, inflammation, and myocardial remodeling, forming a vicious circle. Conclusion. The accumulated data indicate that chronic venous insufficiency of the lower extremities and chronic heart failure are interrelated, and their combination worsens the prognosis. Further research is needed to clarify the mechanisms underlying the cause-and-effect relationship and to develop a comprehensive therapy.
- 5 March 2026
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 29 (2) , 103-108
Relationship between chronic heart and venous insufficiency: possible mechanisms and clinical research findings
Chronic venous insufficiency (CVI) of the lower extremities is common and was once considered a localized disease. Recent evidence shows systemic effects of CVI, especially its link to the onset and progression of chronic heart failure (CHF). Objective. To characterize the possible relationships between chronic venous insufficiency of the lower extremities and chronic heart failure, to analyze the pathophysiological mechanisms of their interaction, as well as the role of chronic venous insufficiency of the lower extremities as a predictor of the development and progression of chronic heart failure. Materials and methods. The article reviews publications indicating a possible relationship between CVI and CHF. Sources were identified by searching the PubMed, eLibrary, and Google Scholar databases. Articles available in full-text, published from 2006 to 2025, were selected. Results. CVI has been shown to be associated with an increased risk of CHF, mortality, and adverse cardiovascular outcomes. Venous congestion and right heart dysfunction induce endothelial dysfunction, inflammation, and myocardial remodeling, forming a vicious circle. Conclusion. The accumulated data indicate that chronic venous insufficiency of the lower extremities and chronic heart failure are interrelated, and their combination worsens the prognosis. Further research is needed to clarify the mechanisms underlying the cause-and-effect relationship and to develop a comprehensive therapy.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12)
Endovascular treatment of post-thrombotic ileocaval-femoral venous obstruction. A case report
According to widely published data, intravascular imaging (IVI)-guided endovascular venous stenting is an effective and safe alternative to open reconstructive surgery of the iliofemoral venous segment. Data on the potential of endovascular treatments for the ileocaval segment are currently insufficient. However, for some patients, this minimally invasive reconstructive surgery may be a viable alternative to open surgery. This article presents the case of a 48-year-old patient with severe postthrombotic disease, severe venous claudication, bilateral ileofemoral obstruction, and extensive occlusion of the infrarenal part of the inferior vena cava. Single-step endovascular IVI-guided recanalization and reconstruction of the ileocaval-femoral segment was performed with implantation of Abre™ and Wallstent™ venous stents. After 6 months, we revealed a decrease in venous hypertension symptoms, an increase in walking distance, a decrease in postthrombotic syndrome severity according to Villalta score, and an improvement in the Venous Clinical Severity Score.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12)
Endovascular treatment of post-thrombotic ileocaval-femoral venous obstruction. A case report
According to widely published data, intravascular imaging (IVI)-guided endovascular venous stenting is an effective and safe alternative to open reconstructive surgery of the iliofemoral venous segment. Data on the potential of endovascular treatments for the ileocaval segment are currently insufficient. However, for some patients, this minimally invasive reconstructive surgery may be a viable alternative to open surgery. This article presents the case of a 48-year-old patient with severe postthrombotic disease, severe venous claudication, bilateral ileofemoral obstruction, and extensive occlusion of the infrarenal part of the inferior vena cava. Single-step endovascular IVI-guided recanalization and reconstruction of the ileocaval-femoral segment was performed with implantation of Abre™ and Wallstent™ venous stents. After 6 months, we revealed a decrease in venous hypertension symptoms, an increase in walking distance, a decrease in postthrombotic syndrome severity according to Villalta score, and an improvement in the Venous Clinical Severity Score.
- Open Access
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4676
Venous system in patients with heart failure and lower extremity edema: rationale and design of a clinical trial
There is reason to believe that there are bidirectional relationships between heart failure (HF) and lower extremity chronic venous insufficiency (CVI). In particular, CVI is considered not only a local disease but also a condition with a systemic hemodynamic impact. However, accumulated data on the relationship between HF and venous system appear largely limited and fragmented. The existing literature lacks studies that have comprehensively assessed the venous system in patients with HF and lower extremity edema, and does not provide information on the prognostic value of such an assessment. This prospective cohort clinical study aims to determine possible associations between HF and venous system status, taking into account CVI, analyze the clinical and pathophysiological mechanisms underlying their interaction, and assess the significance of CVI as a potential predictor of HF progression. The study will include hospitalized patients with HF who have had diuretic therapy initiated or intensified in hospital. Upon admission and discharge, an echocardiogram will be performed to assess right heart function, an lower extremity vein ultrasound, and laser Doppler flowmetry, including the orthostatic and Valsalva maneuvers. The severity of congestion will be assessed based on bioelectrical impedance analysis, lung and abdomen ultrasound, including the VExUS protocol. A separate analysis will be conducted for patients with and without CVI. After 6 months, the incidence of death and rehospitalization due to heart failure will be determined via telephone contact.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4676
Open AccessVenous system in patients with heart failure and lower extremity edema: rationale and design of a clinical trial
There is reason to believe that there are bidirectional relationships between heart failure (HF) and lower extremity chronic venous insufficiency (CVI). In particular, CVI is considered not only a local disease but also a condition with a systemic hemodynamic impact. However, accumulated data on the relationship between HF and venous system appear largely limited and fragmented. The existing literature lacks studies that have comprehensively assessed the venous system in patients with HF and lower extremity edema, and does not provide information on the prognostic value of such an assessment. This prospective cohort clinical study aims to determine possible associations between HF and venous system status, taking into account CVI, analyze the clinical and pathophysiological mechanisms underlying their interaction, and assess the significance of CVI as a potential predictor of HF progression. The study will include hospitalized patients with HF who have had diuretic therapy initiated or intensified in hospital. Upon admission and discharge, an echocardiogram will be performed to assess right heart function, an lower extremity vein ultrasound, and laser Doppler flowmetry, including the orthostatic and Valsalva maneuvers. The severity of congestion will be assessed based on bioelectrical impedance analysis, lung and abdomen ultrasound, including the VExUS protocol. A separate analysis will be conducted for patients with and without CVI. After 6 months, the incidence of death and rehospitalization due to heart failure will be determined via telephone contact.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12)
Endovascular treatment of post-thrombotic ileocaval-femoral venous obstruction. A case report
According to widely published data, intravascular imaging (IVI)-guided endovascular venous stenting is an effective and safe alternative to open reconstructive surgery of the iliofemoral venous segment. Data on the potential of endovascular treatments for the ileocaval segment are currently insufficient. However, for some patients, this minimally invasive reconstructive surgery may be a viable alternative to open surgery. This article presents the case of a 48-year-old patient with severe postthrombotic disease, severe venous claudication, bilateral ileofemoral obstruction, and extensive occlusion of the infrarenal part of the inferior vena cava. Single-step endovascular IVI-guided recanalization and reconstruction of the ileocaval-femoral segment was performed with implantation of Abre™ and Wallstent™ venous stents. After 6 months, we revealed a decrease in venous hypertension symptoms, an increase in walking distance, a decrease in postthrombotic syndrome severity according to Villalta score, and an improvement in the Venous Clinical Severity Score.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12)
Endovascular treatment of post-thrombotic ileocaval-femoral venous obstruction. A case report
According to widely published data, intravascular imaging (IVI)-guided endovascular venous stenting is an effective and safe alternative to open reconstructive surgery of the iliofemoral venous segment. Data on the potential of endovascular treatments for the ileocaval segment are currently insufficient. However, for some patients, this minimally invasive reconstructive surgery may be a viable alternative to open surgery. This article presents the case of a 48-year-old patient with severe postthrombotic disease, severe venous claudication, bilateral ileofemoral obstruction, and extensive occlusion of the infrarenal part of the inferior vena cava. Single-step endovascular IVI-guided recanalization and reconstruction of the ileocaval-femoral segment was performed with implantation of Abre™ and Wallstent™ venous stents. After 6 months, we revealed a decrease in venous hypertension symptoms, an increase in walking distance, a decrease in postthrombotic syndrome severity according to Villalta score, and an improvement in the Venous Clinical Severity Score.
- Open Access
- 28 December 2023
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 19 (6) , 542-548
Endovenous laser ablation of great saphenous vein and pharmacotherapy of acute ascending thrombophlebitis: results of a three-month follow-up
Aim. In patients with acute ascending thrombophlebitis of the great saphenous vein and/or its large tributaries, assess the incidence of venous thrombosis progression over 3 months with 1,5-month fondaparinux sodium therapy and endovenous laser ablation of the saphenofemoral junction in combination with short-term (7-day) anticoagulant therapy or without anticoagulation.Material and methods. This single-center, prospective, randomized, open-label study included data from 91 patients with acute ascending thrombophlebitis of the great saphenous vein and/or its large tributaries, of which 30 were in the group of endovenous laser ablation without anticoagulation, 32 — in the group of endovenous laser ablation in combination with 7-day fondaparinux therapy, and 29 — in the 1,5-month fondaparinux therapy group. Venous thrombosis progression rate within 90±2 days was assessed. Compression ultrasonography of lower limb veins was performed on days 7±2, 45±2 and 90±2 after randomization, as well as in case of thrombosis progression suspicion.Results. The mean age of patients was 49,4±14,2 years. There were more women (73,6%). There was a low prevalence of risk factors for the development and progression of venous thrombosis: obesity — 6,6%, type 2 diabetes — in 2 patients, class 2 heart failure — in 1, autoimmune disease (scleroderma in remission) — in 1, prior cancer — in 1. Previous episodes of thrombophlebitis were noted in 3 cases (3,3%). Following external factors provoking venous thrombosis were identified in 19 patients (20,9%): lower leg injury in 14, high physical activity in 3, long flight in 1, recent coronavirus disease 2019 in 1. Median duration of thrombophlebitis manifestations was 6 days. Thrombosis was located in the trunk of the great saphenous vein in 96,7% of patients, while large tributaries were involved in 29,7%. The median distance from the thrombus proximal part to the saphenofemoral junction was 42,5 cm. Over 90±2 days, there were no cases of involvement of the suprafascial segment of the perforating vein in thrombosis to the fascia level, spread of thrombosis to the deep veins, or pulmonary embolism. Subsequently, a new episode of superficial vein thrombosis was noted only in 2 patients from the pharmacotherapy group with a history of thrombophlebitis.Conclusion. In patients with a low risk of venous thrombosis progression and predominantly distal location of acute ascending thrombophlebitis of the great saphenous vein and/or its large tributaries after endovenous laser ablation, progression of venous thrombosis is not expected over the next 3 months, despite an anticoagulation reduction to 7 days or its refusal.
- 28 December 2023
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 19 (6) , 542-548
Open AccessEndovenous laser ablation of great saphenous vein and pharmacotherapy of acute ascending thrombophlebitis: results of a three-month follow-up
Aim. In patients with acute ascending thrombophlebitis of the great saphenous vein and/or its large tributaries, assess the incidence of venous thrombosis progression over 3 months with 1,5-month fondaparinux sodium therapy and endovenous laser ablation of the saphenofemoral junction in combination with short-term (7-day) anticoagulant therapy or without anticoagulation.Material and methods. This single-center, prospective, randomized, open-label study included data from 91 patients with acute ascending thrombophlebitis of the great saphenous vein and/or its large tributaries, of which 30 were in the group of endovenous laser ablation without anticoagulation, 32 — in the group of endovenous laser ablation in combination with 7-day fondaparinux therapy, and 29 — in the 1,5-month fondaparinux therapy group. Venous thrombosis progression rate within 90±2 days was assessed. Compression ultrasonography of lower limb veins was performed on days 7±2, 45±2 and 90±2 after randomization, as well as in case of thrombosis progression suspicion.Results. The mean age of patients was 49,4±14,2 years. There were more women (73,6%). There was a low prevalence of risk factors for the development and progression of venous thrombosis: obesity — 6,6%, type 2 diabetes — in 2 patients, class 2 heart failure — in 1, autoimmune disease (scleroderma in remission) — in 1, prior cancer — in 1. Previous episodes of thrombophlebitis were noted in 3 cases (3,3%). Following external factors provoking venous thrombosis were identified in 19 patients (20,9%): lower leg injury in 14, high physical activity in 3, long flight in 1, recent coronavirus disease 2019 in 1. Median duration of thrombophlebitis manifestations was 6 days. Thrombosis was located in the trunk of the great saphenous vein in 96,7% of patients, while large tributaries were involved in 29,7%. The median distance from the thrombus proximal part to the saphenofemoral junction was 42,5 cm. Over 90±2 days, there were no cases of involvement of the suprafascial segment of the perforating vein in thrombosis to the fascia level, spread of thrombosis to the deep veins, or pulmonary embolism. Subsequently, a new episode of superficial vein thrombosis was noted only in 2 patients from the pharmacotherapy group with a history of thrombophlebitis.Conclusion. In patients with a low risk of venous thrombosis progression and predominantly distal location of acute ascending thrombophlebitis of the great saphenous vein and/or its large tributaries after endovenous laser ablation, progression of venous thrombosis is not expected over the next 3 months, despite an anticoagulation reduction to 7 days or its refusal.
- Open Access
- 27 December 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (12) , 3850
Endovascular treatment of lead-related superior vena cava syndrome after pacemaker implantation
Superior vena cava syndrome (SVCS) is due to impaired venous outflow from the head, neck, limbs and upper half of the body into the right atrium due to stenosis or complete obstruction of the superior vena cava (SVC). Increased venous pressure in the SVC and lack of timely treatment leads not only to serious complications, but also to death. In recent years, the etiology of SVCS has changed dramatically, mainly due to an increase in the number of implanted intravascular devices (central venous catheters, pacemakers, defibrillators, and other devices). Endovascular methods have become widely used in the treatment of patients with SVCS. This was primarily due to the minimally invasive nature of the intervention, the high technical success of the operation and the rapid onset of clinical improvement. Patients who develop SVCS after device implantation are predominantly younger and have a longer life expectancy. When choosing a treatment method, it is extremely important to take these factors into account and give preference to methods providing a long-term effect with the fewest possible complications. The article presents a case of endovascular treatment of a patient with SVCS occlusion, which developed 9 years after pacemaker implantation, using intravascular imaging methods.
- 27 December 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (12) , 3850
Open AccessEndovascular treatment of lead-related superior vena cava syndrome after pacemaker implantation
Superior vena cava syndrome (SVCS) is due to impaired venous outflow from the head, neck, limbs and upper half of the body into the right atrium due to stenosis or complete obstruction of the superior vena cava (SVC). Increased venous pressure in the SVC and lack of timely treatment leads not only to serious complications, but also to death. In recent years, the etiology of SVCS has changed dramatically, mainly due to an increase in the number of implanted intravascular devices (central venous catheters, pacemakers, defibrillators, and other devices). Endovascular methods have become widely used in the treatment of patients with SVCS. This was primarily due to the minimally invasive nature of the intervention, the high technical success of the operation and the rapid onset of clinical improvement. Patients who develop SVCS after device implantation are predominantly younger and have a longer life expectancy. When choosing a treatment method, it is extremely important to take these factors into account and give preference to methods providing a long-term effect with the fewest possible complications. The article presents a case of endovascular treatment of a patient with SVCS occlusion, which developed 9 years after pacemaker implantation, using intravascular imaging methods.
- Open Access
- 27 December 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (12) , 3863
Endovenous laser ablation and drug treatment of acute great saphenous vein ascending thrombophlebitis: comparison of three approaches to the treatment of patients
Aim. In patients with acute thrombophlebitis of the great saphenous vein and/or large tributaries, compare the effectiveness and safety of 1,5-month fondaparinux sodium therapy and endovenous laser ablation in the area of the saphenofemoral junction in combination with shortterm anticoagulation or without anticoagulant therapy. Material and methods . This prospective, single-center, randomized, open-label clinical trial included 105 patients with acute great saphenous vein thrombophlebitis at a distance of at least 5 cm from the saphenofemoral junction. Thirty-four patients were randomized into the group of endovenous laser ablation in the area of the saphenofemoral junction without the anticoagulant therapy. The group of endovenous laser ablation in combination with 7-day fondaparinux sodium included 35 patients, while the group of 1,5-month treatment with fondaparinux sodium — 36. In all cases, class 2 compression stockings were used for 1,5 months. Clinical manifestations of venous thrombosis and its prevalence according to compression ultrasonography were assessed in the first 45±2 days from the start of treatment. Results. The mean age of patients was 49,1±13,7 years. There were more women (73,3%). The prevalence of risk factors for the occurrence and progression of venous thrombosis was low. Previous episodes of thrombophlebitis were observed in 3 (2,9%) patients. External factors that could provoke venous thrombosis were identified in 21 (20,0%) patients. Thrombosis was located in the great saphenous vein in 97,1% of patients, while large tributaries were involved in 25,7% of cases. The median distance from the proximal thrombus to the saphenofemoral junction was 45,2 cm. Patients randomized to the pharmacotherapy group were significantly older (mean age 49,1±13,7, 45,9±13,3 and 53,8±13,2 years, respectively; p=0,032), had slightly less pain and swelling. In all patients, after endovascular laser obliteration, a stable flow cessation at the intervention site was achieved. There were no cases of progression of venous thrombosis. After 7±2 days, in all groups there was a significant decrease in the proportion of patients with clinical manifestations of venous thrombosis, as well as the severity of persistent clinical manifestations. After 45±2 days, clinical manifestations were observed in a few patients and their severity was minimal. However, in the drug treatment group, a more frequent persistence of edema was noted both after 7±2 days (26,5, 20,0 and 47,7%, respectively; p=0,036) and after 45±2 days, (0, 2,9 and 16,7%, respectively; p=0,01). Hematomas and bruises were exclusive hemorrhagic complications. Hematomas were revealed in groups with endovenous laser ablation only. All hemorrhagic complication were minor according to World Society of Thrombosis and Hemostasis (ISTH) and type 1 according to Academic Research Consortium (BARC) classifications. Conclusion. In outpatients with low risk of recurrence and mainly distal localization of acute thrombophlebitis of the great saphenous vein and/ or large inflows, endovenous laser ablation close to saphenous vein junction without anticoagulation or with 7 days of anticoagulation and medical treatment with 1,5-month anticoagulation had comparable efficacy and invasive treatment was sufficiently safe.
- 27 December 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (12) , 3863
Open AccessEndovenous laser ablation and drug treatment of acute great saphenous vein ascending thrombophlebitis: comparison of three approaches to the treatment of patients
Aim. In patients with acute thrombophlebitis of the great saphenous vein and/or large tributaries, compare the effectiveness and safety of 1,5-month fondaparinux sodium therapy and endovenous laser ablation in the area of the saphenofemoral junction in combination with shortterm anticoagulation or without anticoagulant therapy. Material and methods . This prospective, single-center, randomized, open-label clinical trial included 105 patients with acute great saphenous vein thrombophlebitis at a distance of at least 5 cm from the saphenofemoral junction. Thirty-four patients were randomized into the group of endovenous laser ablation in the area of the saphenofemoral junction without the anticoagulant therapy. The group of endovenous laser ablation in combination with 7-day fondaparinux sodium included 35 patients, while the group of 1,5-month treatment with fondaparinux sodium — 36. In all cases, class 2 compression stockings were used for 1,5 months. Clinical manifestations of venous thrombosis and its prevalence according to compression ultrasonography were assessed in the first 45±2 days from the start of treatment. Results. The mean age of patients was 49,1±13,7 years. There were more women (73,3%). The prevalence of risk factors for the occurrence and progression of venous thrombosis was low. Previous episodes of thrombophlebitis were observed in 3 (2,9%) patients. External factors that could provoke venous thrombosis were identified in 21 (20,0%) patients. Thrombosis was located in the great saphenous vein in 97,1% of patients, while large tributaries were involved in 25,7% of cases. The median distance from the proximal thrombus to the saphenofemoral junction was 45,2 cm. Patients randomized to the pharmacotherapy group were significantly older (mean age 49,1±13,7, 45,9±13,3 and 53,8±13,2 years, respectively; p=0,032), had slightly less pain and swelling. In all patients, after endovascular laser obliteration, a stable flow cessation at the intervention site was achieved. There were no cases of progression of venous thrombosis. After 7±2 days, in all groups there was a significant decrease in the proportion of patients with clinical manifestations of venous thrombosis, as well as the severity of persistent clinical manifestations. After 45±2 days, clinical manifestations were observed in a few patients and their severity was minimal. However, in the drug treatment group, a more frequent persistence of edema was noted both after 7±2 days (26,5, 20,0 and 47,7%, respectively; p=0,036) and after 45±2 days, (0, 2,9 and 16,7%, respectively; p=0,01). Hematomas and bruises were exclusive hemorrhagic complications. Hematomas were revealed in groups with endovenous laser ablation only. All hemorrhagic complication were minor according to World Society of Thrombosis and Hemostasis (ISTH) and type 1 according to Academic Research Consortium (BARC) classifications. Conclusion. In outpatients with low risk of recurrence and mainly distal localization of acute thrombophlebitis of the great saphenous vein and/ or large inflows, endovenous laser ablation close to saphenous vein junction without anticoagulation or with 7 days of anticoagulation and medical treatment with 1,5-month anticoagulation had comparable efficacy and invasive treatment was sufficiently safe.
- Open Access
- 1 March 2023
- Published by Remedium, Ltd. in Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)
- Vol. 20 (1) , 174-184
Endovenous laser coagulation of varicose veins: evolution continues
The article discusses the evolution of the endovenous laser ablation technique for the treatment of varicose vein disease of lower extremities. The history of studies aimed at improving the endovenous laser ablation is provided. The authors described the features of endovenous laser ablation with wavelengths from λ = 0.445 to 1.94 µm, alongside with edge- and radial-emitting working fibers, as well as fibers with radiation absorption at its distal end. The physical and biophysical mechanisms of the most popular to-date method for outpatient treatment of varicose vein disease of lower extremities are reviewed. The propagation process of laser radiation in the scattering medium is described, and the important role of the radiation scattering effect on the depth of its penetration into biological tissues is shown. The processes that take place during endovenous laser ablation are considered. The difference in physical processes that take place during the use of laser radiation mainly absorbed by hemoglobin (hemoglobin-absorbed range) and by water (water-absorbed range) is described. Expedience of simulating the processes that take place during endovenous laser ablation with the use of blood plasma has been substantiated. The blood plasma simulation demonstrated the decisive action of laser-induced boiling on thermal damage to the vein wall, which causes its fibrous transformation. It has been shown that the use of radial-emitting fibres during intense boiling generates steam bubbles around the site of radiation coupling. The contents of such steam bubbles do not absorb radiation, which thus reaches the venous wall, causing its symmetrical thermal damage. The advantages of using water-absorbing radiation with a wavelength of λ = 1.94 µm in conjunction with a radial-emitting fibre have been substantiated.
- 1 March 2023
- Published by Remedium, Ltd. in Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)
- Vol. 20 (1) , 174-184
Open AccessEndovenous laser coagulation of varicose veins: evolution continues
The article discusses the evolution of the endovenous laser ablation technique for the treatment of varicose vein disease of lower extremities. The history of studies aimed at improving the endovenous laser ablation is provided. The authors described the features of endovenous laser ablation with wavelengths from λ = 0.445 to 1.94 µm, alongside with edge- and radial-emitting working fibers, as well as fibers with radiation absorption at its distal end. The physical and biophysical mechanisms of the most popular to-date method for outpatient treatment of varicose vein disease of lower extremities are reviewed. The propagation process of laser radiation in the scattering medium is described, and the important role of the radiation scattering effect on the depth of its penetration into biological tissues is shown. The processes that take place during endovenous laser ablation are considered. The difference in physical processes that take place during the use of laser radiation mainly absorbed by hemoglobin (hemoglobin-absorbed range) and by water (water-absorbed range) is described. Expedience of simulating the processes that take place during endovenous laser ablation with the use of blood plasma has been substantiated. The blood plasma simulation demonstrated the decisive action of laser-induced boiling on thermal damage to the vein wall, which causes its fibrous transformation. It has been shown that the use of radial-emitting fibres during intense boiling generates steam bubbles around the site of radiation coupling. The contents of such steam bubbles do not absorb radiation, which thus reaches the venous wall, causing its symmetrical thermal damage. The advantages of using water-absorbing radiation with a wavelength of λ = 1.94 µm in conjunction with a radial-emitting fibre have been substantiated.